BlueNord ASA (OSL:BNOR)

Marinus Pharmaceuticals Revenue

BlueNord ASA had revenue of $260.20M USD in the quarter ending June 30, 2025, with 52.34% growth. This brings the company's revenue in the last twelve months to $794.30M, up 9.85% year-over-year. In the year 2024, BlueNord ASA had annual revenue of $702.30M, down -11.66%.

• Revenue (ttm): $794.30M
• Revenue Growth: +9.85%
• P/S Ratio: 1.59
• Revenue / Employee: $19.40M
• Employees: 41
• Market Cap: 12.80B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	702.30M	-92.70M	-11.66%
Dec 31, 2023	795.00M	-171.90M	-17.78%
Dec 31, 2022	966.90M	401.60M	71.04%
Dec 31, 2021	565.30M	-700.00K	-0.12%
Dec 31, 2020	566.00M	233.00M	69.97%